Clinical Trials in Georgia

Showing 4961-4980 of 14,426 trials

A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

NCT06267274

A randomized, double-blind, parallel-group, two-arm, multiple dose, multicenter, clinical endpoint bioequivalence study

Amneal Pharmaceuticals, LLC240 participantsStarted Apr 2024

Bakersfield, California, United States • Newport Beach, California, United States • Morrow, Georgia, United States +1 more locations

No Longer Available65 miles

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

NCT05462639

Elranatamab is a bispecific antibody: binding of elranatamab to CD3- expressing T-cell and BCMA- expressing multiple myeloma cells causes targeted T-cell mediated cytotoxicity. This expanded access protocol will provide access to elranatamab until it becomes commercially accessible to patients who are refractory to at least one proteasome inhibitor, one immunomodulatory drug and one anti-CD38 antibody and have no access to other comparable/alternative therapy and for whom elranatamab could be a possible treatment option.

Multiple Myeloma

Pfizer

Los Angeles, California, United States • Los Angeles, California, United States • Orange, California, United States +33 more locations

A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

Find Trials by Condition in Georgia

A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism

Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media

HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis

Smoking Cessation Behavioral Treatment Study

Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide

Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma

Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma

An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

Hypertrophic Cardiomyopathy Federated Learning Implementation Platform

Evaluation of the Tympanostomy Tube Delivery System

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test

An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa

Training for Health Professionals In Tanzania